Table TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type [see all tables in this series...]

Part (v) All clients with stimulants other than cocaine as primary drug type: number of episodes reporting the stated drug as secondary

Country	Opioids	Cocaine	Other stimulants	Hypnotics/sedatives	Hallucinogens	Volatile substances	Cannabis	Alcohol	Others
Bulgaria	0	0	0	0	0	0	4	1	5
Czech Republic	83	9	40	16	29	29	432	41	858
Denmark	42	82	79	50	23	6	102	108	770
Germany	275	660	3896	133	416	16	1655	766	49
Ireland	2	38	24	1	2	1	52	39	0
Greece	3	1	3	0	1	0	11	4	31
Spain	21	136	33	8	20	1	223	152	817
France	20	52	25	7	23	1	54	24	339
Italy	30	102	40	17	30	18	92	55	612
Cyprus	0	5	0	0	0	0	8	1	14
Latvia	6	0	10	9	1	0	34	11	97
Luxembourg	0	1	0	0	0	0	8	0	9
Malta	5	8	2	3	2	0	9	1	30
Netherlands	23	73	87	10	7	0	167	85	501
Austria	23	45	34	15	18	3	41	46	311
Slovakia	32	16	31	3	8	5	76	13	0
Finland	55	3	17	62	1	2	119	38	1
Sweden	69	32	39	159	19	3	257	200	810
United Kingdom	303	551	496	169	72	16	1327	919	5440
Total	992	1814	4856	662	672	101	4671	2504	10694

Notes:

 Data on secondary drug use are only collected among all treatment clients and not separately for new treatment clients. 

 ‘Opioids’ include: heroin, methadone, other opioids; ‘Cocaine’ includes: cocaine HCl, crack cocaine; ‘Stimulants’ include: amphetamines, MDMA and derivates, other stimulants: ‘Cannabis’ can include herb or resin. For each client up to four secondary drugs can be reported. 

 A number of the clients report using the same drug both as primary and secondary drug, particularly for cannabis. Clients may report using different sub-types of the same substance, as defined in the TDI Protocol for the drugs categories. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007.  

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)